Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
Clinical trial NCT00983346 · TERMINATED
Trial details
- NCT number
- NCT00983346
- Sponsor
- University of Utah
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2014-09-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.